DISCOVER NEURIX
Currently, there are over 600 diseases that affect the central nervous system, inflicting neural damage. Unfortunately, few of these conditions have available and effective treatments. At Neurix, our primary goal lies in pursuing innovation and pioneering breakthrough technologies to challenge this negative trend.
OUR SERVICES
Neurix specializes in human stem cell-based services, catering to neural drug screening and lead compound validation. Our offerings include Efficacy and drug discovery services with a wide range of Cell Models to support your research needs.
NEWS, EVENTS & INNOVATIONS
Our glioblastoma in vitro model, BlastomaBrain™, selected for pre-clinical development in preparation for an FDA IND submission.
“We focus on the development of models of neurodegenerative diseases”
Neurix develops a microglia-embedded cerebral organoid model of Parkinson's disease, in collaboration with Innoser and the University of Geneva
3-DIMENSIONAL NEURAL TISSUE
Neurix provides services for drug discovery and development. We generate physiologically relevant 3-dimensional neural tissues derived from human pluripotent stem cells. Our organoids display accelerated cell maturity that mimics the native brain tissue. Predictive, accurate, and reproducible, our in vitro human cell-based services enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.
We generate two formats of neural organoids to ensure compatibility with high throughput screening, and optimal disease modeling services
- Injectable
- Full genomic / proteomic analysis
- High throughput compatible